Pharmaceutical News

RSS

COVID-19 vaccine inequity increased infection and mortality rates in low and middle-income countries

COVID-19 vaccine inequity exists within and between countries, which impacted disease burden and mortality.

1 Mar 2023

Personal use of psychedelics among therapists may be common, study finds

Whether personal use of psychedelics is appropriate among psychedelic therapists, a new study finds that it may be common.

27 Feb 2023

After capping the price of insulin, Colorado sets its sights on EpiPens

Almost four years after becoming the first state to cap insulin prices, Colorado may limit what consumers pay for epinephrine autoinjectors, also known as EpiPens, which treat serious allergic reactions.

27 Feb 2023

High-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatients

Researchers evaluate the efficacy of ivermectin in a maximum dosage of 600 μg/kg/day over six days in treating early mild-to-moderate COVID-19.

27 Feb 2023

Study highlights COVID-19 vaccine safety among children

Researchers evaluate COVID-19 vaccine-associated serious adverse events following immunization among five- to 17-year-old children.

23 Feb 2023

Preventative antibiotic given during labor can reduce the risk of sepsis and death

A single oral dose of the antibiotic azithromycin given during labor can dramatically reduce the risk of sepsis and death among women following childbirth, according to a large multi-country clinical trial, as a UN report warns of "stagnation" in maternal health.

23 Feb 2023

CDC evaluation of the efficacy of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection in 3 to 5-year-olds

The complete primary series monovalent mRNA vaccines protect children aged three to five against symptomatic infection for up to four months.

22 Feb 2023

CDC provides vaccine efficacy estimates of Pfizer and Moderna vaccines in kids ages 3-5

Vaccination coverage among infants and children varied according to age, race and ethnicity, jurisdiction, and rural and urban settings

22 Feb 2023

Analysis examines which non-opioid drugs are best for treating acute low back pain

Acute low back pain is a common cause of disability. An analysis in the Journal of Orthopaedic Research examined which non-opioid drugs are best for treating this condition.

22 Feb 2023

A bitter battle over the ‘orphan drug’ program leaves patients’ pocketbooks at risk

A prescription drug that helps Lore Wilkinson walk and talk despite a rare muscle disease cost her so little for more than a decade that she didn't even use her insurance to pay for it.

22 Feb 2023

Specific group of COVID-19 patients benefits the most from remdesivir, new analysis shows

Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results.

22 Feb 2023

Skin medication shows promise in treating alcohol use disorder

Researchers from Oregon Health & Science University and institutions across the country have identified a pill used to treat a common skin disease as an "incredibly promising" treatment for alcohol use disorder.

21 Feb 2023

Ethnic and regional minorities derive at least as much cardiovascular benefit from lipid-lowering therapies

Minority ethnicities and regions derive at least as much cardiovascular benefit from lipid-lowering therapies as majority groups despite being underrepresented in clinical trials, according to a study published today in the European Journal of Preventive Cardiology, a journal of the ESC.

21 Feb 2023

MHRA authorizes new version of the Moderna ‘bivalent’ Covid vaccine

Authorization has today been granted by the Medicines and Healthcare products Regulatory Agency (MHRA) for a new version of the Moderna 'bivalent' Covid vaccine (Spikevax) that targets both the original strain of SARS-CoV-2 and the Omicron BA.4 and BA.5 sub-variants.

21 Feb 2023

Research examines antibiotic use during COVID-19 by age

In a research letter published in JAMA Health Forum, researchers evaluated antibiotic prescriptions during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-associated health visits in outpatient settings by United States (US) residents aged ≤64 years who have commercial health insurance.

20 Feb 2023

After a previous BA.1 infection, Omicron BA.4/5 infection is more likely than BA.2

In a recent study published in the journal Eurosurveillance, researchers investigated whether prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or coronavirus disease 2019 (COVID-19) vaccination protected against SARS-CoV-2 Omicron variant of concern (VOC) BA.4/5 sub-VOC or BA.2 sub-VOC infections.

19 Feb 2023

How effective has the bivalent booster COVID vaccination been?

In a recent study published in the journal Eurosurveillance, researchers estimated the effectiveness of bivalent messenger ribonucleic acid (mRNA) vaccines targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1 subvariant and the original Wuhan-Hu1 strain against Omicron infections in the vaccinated population of the Netherlands between 26 September and 19 December 2022.

19 Feb 2023

Are SGLT2 inhibitors the next blockbuster drug?

Previous
1
...
66
67
68
69
70
71
72
...
1443
Next

Pharmaceutical News

COVID-19 vaccine inequity increased infection and mortality rates in low and middle-income countries

Personal use of psychedelics among therapists may be common, study finds

After capping the price of insulin, Colorado sets its sights on EpiPens

High-dose ivermectin does not reduce COVID-19 symptom duration among mild-to-moderate outpatients

Study highlights COVID-19 vaccine safety among children

Preventative antibiotic given during labor can reduce the risk of sepsis and death

CDC evaluation of the efficacy of monovalent mRNA vaccines in preventing symptomatic SARS-CoV-2 infection in 3 to 5-year-olds

CDC provides vaccine efficacy estimates of Pfizer and Moderna vaccines in kids ages 3-5

Analysis examines which non-opioid drugs are best for treating acute low back pain

A bitter battle over the ‘orphan drug’ program leaves patients’ pocketbooks at risk

Specific group of COVID-19 patients benefits the most from remdesivir, new analysis shows

Skin medication shows promise in treating alcohol use disorder

Ethnic and regional minorities derive at least as much cardiovascular benefit from lipid-lowering therapies

MHRA authorizes new version of the Moderna ‘bivalent’ Covid vaccine

Research examines antibiotic use during COVID-19 by age

After a previous BA.1 infection, Omicron BA.4/5 infection is more likely than BA.2

How effective has the bivalent booster COVID vaccination been?

Are SGLT2 inhibitors the next blockbuster drug?

Mark Cuban has been taking on the drug industry. But which one?

Pharma companies could provide new, affordable drugs by refocusing their spending, experts say

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News